Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Making NIH pristine

Making NIH pristine

Employee-related recommendations
•Prohibit consulting with pharma or biotech companies, and paid consulting with academia, by NIH senior management and extramural employees who are responsible for program funding decisions and recommendations, and by professional staff managing

Read the full 386 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE